Aker BioMarine | AKBM Logo | Annual Report & Investor Relations Data

Aker BioMarine | AKBM - Annual Report & Investor Relations Data

Aker BioMarine | AKBM
Annual Report & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Ticker

AKBM

Sector

Health Care

Industry

Biotechnology

Country

Norway

Year Founded

2006

Aker BioMarine (AKBM)

About Aker BioMarine

Aker BioMarine was created because of our strong belief in the positive health effects of krill. More than a decade later, our business continues to grow because we take care of the ecosystem we harvest in. To us, it makes no sense to take something out of the ocean to improve our health, if it simultaneously compromises the health of the ocean. Ensuring the well-being of the krill biomass and contributing towards a thriving Antarctic ecosystem are among our core priorities.

The unique phospholipid-bound omega-3s in krill can help reduce the risk of several lifestyle diseases, including heart and brain-related issues. Aker BioMarine has taken on a global challenge to raise awareness about the importance of omega-3s. In 2020, 1,6 billion doses of Superba Krill were sold worldwide, improving the health of millions of people.

Market Presence

Worldwide

Headquarters

Oksenøyveien 10
1366, Lysaker
Norway

Company Video

Video thumbnail
Click to load video from YouTube

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Aker BioMarine (AKBM)
Filings & Annual Reports

Filters

View all types
Filing Information Actions

Aker BioMarine (AKBM)
Stock & Investor Information

ISINs

NO0010886625
NO0013326025

LEI

549300V34T6VWDSYWE64

Stock Exchange Listings

Oslo Børs

Primary Stock Exchange Listing

View Aker BioMarine on main stock exchange

Industry Classification

Aker BioMarine (AKBM)
Related Companies & Peer Group

1NKEMIA Logo

1NKEMIA

IKM

Sector

Health Care

Country

Spain

ISIN

Founded

1NKEMIA specializes in biotechnology research and innovation, offering advanced solutions for the pharmaceutical, chemical, and energy sectors.

2cureX AB Logo

2cureX AB

2CUREX

Sector

Health Care

Country

Sweden

ISIN

SE0010468124

Founded

2cureX AB is a Danish biotech company specializing in functional precision medicine. It develops diagnostic tools to personalize cancer treatment.

4SC AG Logo

4SC AG

VSC

Sector

Health Care

Country

Germany

ISIN

DE000A3E5C40

Founded

1997

4SC focuses on the development of novel small molecule drugs that target key mechanisms of cancer development, such as histone …

Abera Bioscience AB Logo

Abera Bioscience AB

ABERA

Sector

Health Care

Country

Sweden

ISIN

SE0015245097

Founded

Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed …

ABIONYX Pharma Logo

ABIONYX Pharma

ABNX

Sector

Health Care

Country

France

ISIN

FR0012616852

Founded

ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there …

Abliva Logo

Abliva

ABLI

Sector

Health Care

Country

Sweden

ISIN

SE0002575340

Founded

2000

Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when …